Elevated C-reactive protein: Another component of the atherothrombotic profile of abdominal obesity

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 6, 2001, Pages 961-967

  Lemieux, Isabelle ^a   Pascot, Agnès ^a   Prud'homme, Denis ^a   Alméras, Natalie ^a   Bogaty, Peter ^a   Nadeau, André ^a   Bergeron, Jean ^a   Després, Jean Pierre ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Body composition; C reactive protein; Glucose insulin homeostasis; Lipoprotein lipid profile

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; ATHEROSCLEROSIS; BODY COMPOSITION; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL;

EID: 0035717514     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.6.961     Document Type: Article

References (48)

1. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers
2. The pathogenesis of atherosclerosis: Atherogenesis and inflammation
3. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
4. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
5. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
6. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project
7. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial
8. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
9. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
10. Novel inflammatory markers of coronary risk: Theory versus practice
11. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects
12. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
13. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
14. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
15. Interleukin-6 and the acute phase response
16. Relation of components of insulin resistance syndrome to coronary disease risk
17. Contribution of intraabdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity
18. Adiposity, fat distribution, and cardiovascular risk
19. Volume of the lung determined by helium dilution
20. The gross composition of the body
21. Standardization of anthropometric measurements
22. Assessment of adipose tissue distribution by computed axial tomography in obese women: Association with body density and anthropometric measurements
23. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
24. Sur un dosage rapide du cholestérol lié aux β-lipoprotéines du sérum
25. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
26. Increase in plasma high density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma
27. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
28. Zur Bestimmung der Plasmaglukosekonzentration mit der Hexokinase-Glucose-6-Phosphat-Dehydrogenase-Methode
29. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays
30. Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum
31. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
32. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
33. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease
34. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance
35. The acute metabolic effects of tumor necrosis factor administration in humans
36. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation
37. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity
38. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo
39. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects
40. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women
41. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue
42. Involvement of the hemostatic system in the insulin resistance syndrome: A study of 1500 patients with angina pectoris: The ECAT Angina Pectoris Study Group
43. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
44. The acute phase response
45. Role of cytokines in inducing hyperlipidemia
46. Long-term effects of pravastatin on plasma concentration of C-reactive protein: The Cholesterol and Recurrent Events (CARE) Investigators
47. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators